Very few commercial drug companies focus on hearing disorders. Even fewer focus on tinnitus. Otonomy does both. In this exclusive interview, we took a deep dive with Otonomy’s executives into their drug pipeline.
We spoke to David Weber (PhD), President and CEO, and Alan Foster (PhD), Chief Scientific Officer. They shared their views on what they see as the “renaissance” of hearing research and how there is currently more investor appetite to address hearing issues. We discussed why Otonomy is not only seeking solutions for different kinds of hearing loss, but also tinnitus specifically.
The interview covers each of the company’s drugs in-depth, from its mechanism of action to commercialization plans. Tinnitus drug OTO-313 targets overexcitation of the auditory nerve, which is theorized to cause tinnitus. Which types of tinnitus will benefit remains an open question, but the tinnitus community will no doubt follow the drug’s future with keen interest.
Become a Tinnitus Talk Podcast Patron at https://moretinnitustalk.com for bonus content, video interviews, Ask an Expert series, and more!
Good Tinnitus Science, Bad Tinnitus Science
Revisiting a Friend of Tinnitus Talk - Dr. Josef Rauschecker
Can Sound Silence Tinnitus?
The Man Who Donated a Million Dollars to Tinnitus Research
It’s the Data, Stupid! - Christopher Cederroth and David Stockdale
Tinnitus Realities - Steve and Sean
Tinnitus, Ingrained in the Brain? - Prof. Dirk De Ridder
Objectifying Tinnitus - The Bionics Institute
Visual Snow and Tinnitus - Phantom Phenomena
Tinnitus and the Power of Prediction - Dr. Will Sedley
Hearing Lost and Found - Frequency Therapeutics
Reviving Retigabine for Tinnitus - Thanos Tzounopoulos, PhD
Coronavirus Special: Tinnitus in Times of Quarantine
Healing Hearing, Silencing Tinnitus? - Hough Ear Institute
Transforming Hyperacusis Research - Bryan Pollard
Neuromod's Lenire - Treating Tinnitus the Bimodal Way
Clinical Guidelines for Tinnitus - Status Quo or Way Forward?
Hearing In, Tinnitus Out - Prof. Marcelo Rivolta
Tinnitus Management: Who Cares? - Richard Tyler, PhD
Create your
podcast in
minutes
It is Free
Good Mood Revolution
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
Precision Medicine Forum Podcast
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive